Affiliation:
1. Department of Cardiovascular Medicine Sydell and Arnold Miller Family Heart & Vascular Institute Cleveland Clinic Foundation Cleveland OH
2. Department of Thoracic and Cardiovascular Surgery Sydell and Arnold Miller Family Heart & Vascular Institute Cleveland Clinic Foundation Cleveland OH
Abstract
Background
Concurrent presence of aortic stenosis and aortic regurgitation is termed mixed aortic valve disease (
MAVD
). Although multiple articles have addressed patients with “isolated” aortic stenosis or aortic regurgitation, the natural history, impact, and outcomes of
MAVD
are not well defined. Here, we evaluate long‐term outcomes in patients with
MAVD
and cardiovascular adaptations to chronic
MAVD
.
Methods and Results
This observational cohort study evaluated 862 adult patients (56.8% male) with preserved left ventricular ejection fraction and at least moderate aortic regurgitation and moderate aortic stenosis. Primary outcome was all‐cause mortality. Subgroup analysis was based on treatment modality (aortic valve replacement [
AVR
] versus medical management). A regression analysis of longitudinal echocardiographic parameters was performed to assess the natural history of
MAVD
. Mean age was 68±15 years, and mean left ventricular ejection fraction was 58±5%. At 4.6 years (25th–75th percentile range, 1.0–8.7), 58.6% of patients underwent an
AVR
and 48.8% patients died. In both unadjusted and adjusted Cox survival analysis,
AVR
was associated with improved survival (hazard ratio, 0.41; 95%
CI
, 0.34–0.51,
P
<0.001). Impact of
AVR
persisted when stratifying the cohort by symptom status and baseline aortic valve area (log rank,
P
<0.001 for both) and after propensity‐score matching (hazard ratio, 0.40; 95%
CI
, 0.32–0.50;
P
<0.001). In the longitudinal analysis, there were statistically significant changes over time in aortic valve peak gradient (
P
<0.001) and aortic valve area (
P
<0.001) and only mild increases in left ventricular end‐diastolic (
P
<0.007) and ‐systolic (
P
<0.001) volumes.
Conclusions
MAVD
confers a high risk of all‐cause mortality. However,
AVR
significantly reduces this risk independent of aortic valve area, symptom status, and after controlling for confounding variables.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献